CCL2 and liver dysplastic nodule: To determine the optimal duration and most reasonable dosage of PF in the treatment of DN, four indicators including mesangial expansion index, tubulointerstitial damage index, 24-h urinary protein, and MCP-1 mRNA were selected for the "time-dose analysis" (Fig 11 and S1-S4 Tables in S1 File).